ZIVO has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
ZIVO has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Zivo Bioscience's total inventories for the quarter that ended in Mar. 2024 was $0.00 Mil. Zivo Bioscience's average total inventories from the quarter that ended in Dec. 2023 to the quarter that ended in Mar. 2024 was $0.00 Mil.
In Ben Graham's calculation of Net-Net Working Capital, inventory is only considered worth half of its book value. Zivo Bioscience's Net-Net Working Capital per share for the quarter that ended in Mar. 2024 was $-1.05.
Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Zivo Bioscience's Days Inventory for the three months ended in Mar. 2024 was 0.00.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Zivo Bioscience's Inventory-to-Revenue for the quarter that ended in Mar. 2024 was 0.00.
The historical data trend for Zivo Bioscience's Total Inventories can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Zivo Bioscience Annual Data | |||||||||||||||||||||
Trend | Dec14 | Dec15 | Dec16 | Dec17 | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | |||||||||||
Total Inventories | Get a 7-Day Free Trial | - | - | - | - | - |
Zivo Bioscience Quarterly Data | ||||||||||||||||||||
Jun19 | Sep19 | Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | |
Total Inventories | Get a 7-Day Free Trial | - | - | - | - | - |
Total Inventories includes the raw materials, work-in-process goods and completely finished goods of a company. It is a portion of a company's current assets.
Zivo Bioscience (OTCPK:ZIVO) Total Inventories Explanation
Inventory control is an important part of business operation. If a company does not have enough inventory, it may not be able to meet customers' required delivery time. If it has too much inventory, the cost of holding the inventory can be high.
1. In Ben Graham's calculation of Net-Net Working Capital (NNWC), inventory is only considered worth half of its book value.
Zivo Bioscience's Net-Net Working Capital Per Share for the quarter that ended in Mar. 2024 is
Net-Net Working Capital Per Share (Q: Mar. 2024 ) | |||||||
= | (Cash And Cash Equivalents | + | 0.75 * Accounts Receivable | + | 0.5 * Total Inventories | - | Total Liabilities |
- | Preferred Stock | - | Minority Interest) | / | Shares Outstanding (EOP) | ||
= | (0.139 | + | 0.75 * 0.004 | + | 0.5 * 0 | - | 3.085 |
- | 0 | - | 0) | / | 2.78966 | ||
= | -1.05 |
2. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
Zivo Bioscience's Days Inventory for the three months ended in Mar. 2024 is calculated as:
Days Inventory | = | Average Total Inventories (Q: Mar. 2024 ) | / | Cost of Goods Sold (Q: Mar. 2024 ) | * | Days in Period |
= | 0 | / | 0.023 | * | 365 / 4 | |
= | 0.00 |
3. Inventory Turnover measures how fast the company turns over its inventory within a year.
Zivo Bioscience's Inventory Turnover for the quarter that ended in Mar. 2024 is calculated as
Inventory Turnover | = | Cost of Goods Sold (Q: Mar. 2024 ) | / | Average Total Inventories (Q: Mar. 2024 ) |
= | 0.023 | / | 0 | |
= | N/A |
4. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Zivo Bioscience's Inventory to Revenue for the quarter that ended in Mar. 2024 is calculated as
Inventory-to-Revenue | = | Average Total Inventories (Q: Mar. 2024 ) | / | Revenue (Q: Mar. 2024 ) |
= | 0 | / | 0.036 | |
= | 0.00 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Manufacturers with durable competitive advantages have the advantage that the products they sell do not change, and therefore will never become obsolete. Buffett likes this advantage.
When identifying manufacturers with durable competitive advantage, look for inventory and net earnings that rise correspondingly. This indicates that the company is finding profitable ways to increase sales which called for an increase in inventory.
Manufacturers with inventories that spike up and down are indicative of competitive industries subject to boom and bust.
Thank you for viewing the detailed overview of Zivo Bioscience's Total Inventories provided by GuruFocus.com. Please click on the following links to see related term pages.
Alison A Cornell | director | 210 CARNEGIE CENTER, PRINCETON NJ 08540 |
Christopher D. Maggiore | officer: CHIEF FINANCIAL OFFICER | 4788 NOBLES POND DR. NW, CANTON OH 44718 |
Nola E Masterson | director | 768 WEST CALIFORNIA WAY, WOODSIDE CA 94062 |
John Bernard Payne | director | 9900 NE 114TH CIRCLE, VANCOUVER WA 98662 |
Strome Mezzanine Fund, Lp | 10 percent owner | 100 WILSHIRE BLVD., SUITE 1750, SANTA MONICA CA 90401 |
Keith Marchiando | officer: Chief Financial Officer | C/O ZIVO BIOSCIENCE, INC., 21 E. LONG LAKE ROAD, SUITE 100, BLOOMFIELD HILLS MI 48304 |
Mark E Strome | 10 percent owner | 100 WILSHIRE BLVD, 15TH FL, SANTA MONICA CA 90401 |
Strome Alpha Fund L P | 10 percent owner | 100 WILSHIRE BLVD SUITE 1750, SANTA MONICA CA 90401 |
Strome Investment Management Lp | 10 percent owner | 100 WILSHIRE BLVD, 15TH FLOOR, SANTA MONICA CA 90401 |
Strome Group, Inc. | 10 percent owner | 100 WILSHIRE BLVD., SUITE 1750, SANTA MONICA CA 90401 |
Hep Investments Llc | 10 percent owner | 2804 ORCHARD LAKE RD, STE 205, KEEGO HARBOR MI 48320 |
Rondeau Robert O Jr | director | 70 WEST LONG LAKE RD, STE 119, TROY MI 48098 |
Thomas Kevin Cox | director | 470 MICHGAMME LANE, LAKE FOREST IL 60045 |
Andrew A Dahl | officer: President, CEO | 7 WEST SQUARE LAKE ROAD, STE 6165, BLOOMFIELD HILLS MI 48302 |
Brian W Young | other: See remarks below. | 1800 NW CORPORATE BLVD, BOCA RATON FL 33431 |
From GuruFocus
By Business Wire • 06-30-2023
By Marketwired Marketwired • 08-17-2021
By Business Wire Business Wire • 02-10-2023
By ACCESSWIRE ACCESSWIRE • 01-11-2021
By Business Wire Business Wire • 06-27-2022
By ACCESSWIRE ACCESSWIRE • 07-13-2020
By GlobeNewswire GlobeNewswire • 05-28-2021
By Marketwired Marketwired • 06-02-2021
By Marketwired Marketwired • 10-05-2021
By Business Wire Business Wire • 05-30-2023
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.